Sunday , 19 January 2025
0

No products in the cart.

Worldwide News Worldwide News
0

No products in the cart.

Home Health Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors
Health

Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors

August 2, 20241 Mins read52 Views
Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors

The FDA approved Adaptimmune Therapeutics’ Tecelra as a treatment for advanced cases of synovial sarcoma. It’s the first engineered cell therapy approved for treating a solid tumor.

The post Adaptimmune’s FDA Approval Marks the First for an Engineered Cell Therapy for Solid Tumors appeared first on MedCity News.

Previous post Protesters reportedly set Red Cross vehicle ablaze, vandalise office in Yobe

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Health

AstraZeneca’s Calquence has expanded its FDA approval to include first-line treatment of...

ByJanuary 17, 2025

This interactive chart allows users to track public opinion on the Affordable...

ByJanuary 17, 2025
Health

By MIKE MAGEE In case you’ve missed it, sleep is all the...

ByJanuary 17, 2025
Health

Teladoc Health has joined Amazon’s Health Benefits Connector. Other companies offered through...

ByJanuary 17, 2025

Abous us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis

Subscribe Now

    Subscribe to our mailing list to receives daily updates direct to your inbox!
    © Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com